Evidence Hub

Determinants of Covid-19 Treatment Outcomes among Patients Admitted at an Infectious Disease Centre in sub-Saharan Africa

W. A. Adekunle, M. Salawu, T. Obembe, Waheed Ismail, Idris A. Fasasi, M. D. Bello, O. Fawole

Journal of Global Medicine, 2024

19 participants

Abstract

Background

Although the COVID-19 epidemic seems to have ceased, with only few new sporadic cases seen, reports of new strains of the virus could lead to a resurgence and death. Hence, this study identified the factors influencing COVID-19 treatment outcomes among patients in Ibadan, Nigeria.

Objective

To identify the determinants of COVID-19 treatment outcomes among patients admitted at the Infectious Disease Centre, Olodo, Ibadan, Nigeria.

Method

A facility-based retrospective study was conducted. A review of the records of all cases (932) of laboratory confirmed COVID-19 positive patients, who received treatment between April 2020 and January 2022 at the Centre was conducted. Data was analysed at the level of significance of 5%.

Results

The mean age (S.D.) of the patients was 36.97 (14.6) years, while the mean number of days on admission was 14.87 (11.33) days. Most were males (66.7%). Many (51.5%) were symptomatic at admission, 4% had co-morbidities. The other disease conditions present included obesity, asthma, diabetes and hypertension. At admission, 45.8% had a low body temperature and about a quarter (29.7%) had a high respiratory rate. More than half (63.3%) had a high lymphocyte count, while 41.1% had low neutrophil count. The case fatality rate was 3.3%. Patients’ occupation (OR = 0.56, p = 0.01), pulse rate (OR = 1.00, p = 0.00), blood pressure (OR = 2.97, p = 0.007) and oxygen saturation (OR = 0.05, p = 0.00) were significantly (p <0.05) associated with COVID-19…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free